One Fight, One Future: The Kennedy Effect Aligns Agencies to Eradicate PFAS

Unity reigns across the administration. We call this The Kennedy Effect.

In a landmark shift toward science-driven governance, the EPA’s PFAS crackdown marks the first coordinated victory in a broader movement to deliver on the promises of environmental justice and public health protection.

We are witnessing the unifying Kennedy Effect.

On April 28, 2025, something quietly seismic occurred in Washington: the U.S. Environmental Protection Agency, under Administrator Lee Zeldin, announced a sweeping series of new actions to combat PFAS contamination—actions that not only mark a radical shift in federal environmental policy, but that may also represent the first visible ripple of what’s now being called The Kennedy Effect.

For decades, Americans have lived with PFAS—per- and polyfluoroalkyl substances—also known as "forever chemicals," saturating their drinking water, bloodstreams, and ecosystems. These man-made compounds, found in everything from firefighting foam to food packaging, have been linked to cancer, thyroid dysfunction, developmental delays, and immune suppression. The federal response, until now, has been tepid, defensive, and alarmingly deferential to industry.

That posture is changing.

Important Health Conditions Poised for Decline

Reducing PFAS contamination will likely lead to a measurable and lasting decline in a wide array of serious health conditions that have plagued affected communities for decades. Substantial research has linked exposure to PFAS compounds such as PFOA and PFOS to significantly increased risks of kidney and testicular cancers. A study by Barry, Winquist, and Steenland (2013) found that adults living near PFAS manufacturing plants had markedly higher incidences of both kidney and testicular malignancies compared to the general population. Thyroid dysfunction is another serious outcome: research from Wen et al. (2013) demonstrated that elevated PFAS blood levels disrupt thyroid hormone regulation, potentially leading to hypothyroidism and related metabolic disorders. Liver damage has also emerged as a consistent concern, with Bassler et al. (2019) showing that chronic PFAS exposure correlates with elevated liver enzymes and histological evidence of hepatic apoptosis.

Perhaps most troubling is PFAS impact on the immune system. Grandjean et al. (2012) reported that children with higher serum PFAS levels exhibited significantly reduced antibody responses to routine vaccinations, suggesting that PFAS compromises immune competence. Similarly, prenatal exposure to PFAS has been associated with developmental delays and neurobehavioral disorders such as ADHD and autism spectrum traits, as documented by Liew et al. (2015) in a nested case-control study within the Danish National Birth Cohort. Even at chronic low-dose exposures, PFAS compounds are linked to elevated total and LDL cholesterol (Nelson, Hatch, & Webster, 2010), as well as pregnancy complications including gestational hypertension and preeclampsia (Savitz et al., 2012).

By aggressively curbing new emissions at their industrial sources, remediating existing environmental contamination, and preventing further PFAS migration into drinking water systems, the EPA’s actions—if fully realized and enforced—could significantly reduce the national burden of these preventable, chemically induced diseases. This public health benefit would be particularly transformative in historically underserved or overlooked regions, where disproportionate PFAS exposure has compounded other environmental health disparities for decades.

A Shift in Tone—and Substance

In a news release from the EPA titled “Administrator Zeldin Announces Major EPA Actions to Combat PFAS Contamination” (EPA, 2025), the agency detailed a list of long-overdue initiatives: the creation of effluent limitation guidelines (ELGs) to prevent further pollution, the designation of a centralized agency lead for PFAS coordination, expanded TSCA-based testing strategies, and a new focus on enforcing existing environmental laws that had gone dormant under industry pressure.

Most notably, Zeldin emphasized two principles: holding polluters accountable and protecting “passive receivers”—a term referring to water utilities and communities unfairly saddled with cleanup costs. These tenets stand in stark contrast to prior EPA policies that often favored cost-sharing, liability obfuscation, and prolonged inaction.

The Kennedy Effect Defined

What makes this moment remarkable is not merely the technical details of the announcement—but its unmistakable alignment with the vision long articulated by Robert F. Kennedy Jr., now the head of Health and Human Services. Known for his decades of work exposing environmental crime and regulatory capture, Kennedy has spent much of his career in lonely opposition to the incestuous relationship between federal agencies and corporate polluters.

The Kennedy Effect refers to the emerging shift in federal tone, posture, and philosophy: from corporate appeasement to public defense; from scientific theater to scientific integrity; from bureaucratic delay to active enforcement. While Kennedy himself is not part of the EPA, the cultural effect of his appointment is unmistakable. For the first time in decades, federal agencies appear to be competing to demonstrate accountability.

From “Action Plans” to Actual Action

It’s worth remembering that this is not the EPA’s first PFAS initiative. The 2019 PFAS Action Plan, unveiled with great fanfare under the previous Trump administration, was long on rhetoric and short on teeth. It failed to impose meaningful liability, did not restrict use at the source, and left thousands of communities struggling with unremediated water systems and skyrocketing health costs. The Trump-era EPA held a national leadership summit, collected public comments, and hosted roundtables—then returned quietly to business as usual.

Zeldin’s April 2025 announcement is materially different. Not just in scope, but in moral clarity. The plan prioritizes upstream pollution prevention over downstream crisis management. It embraces statutory authority. It admits the failures of past communication and commits to annual updates to PFAS disposal guidance, rather than once every three years. And it confronts the elephant in the room: liability.

Regulatory Capture Is Losing Its Grip

The most dangerous pollutant in American government isn’t PFAS—it’s captured regulation. For years, industry lobbyists wrote EPA rules behind closed doors, while whistleblowers were sidelined, and citizens were gaslit. Polluters profited while communities got cancer clusters and silence. The cost of this betrayal has been measured not only in dollars, but in trust.

That’s why this shift matters. It’s not merely about PFAS. It’s about restoring the fundamental premise of a republic: that government exists to protect its people, not its corporate patrons.

By declaring unequivocally that “polluter pays” is now guiding EPA policy, and by shielding “passive receivers” from unjust liability, Zeldin’s EPA has broken with the unspoken consensus of the past 30 years.

The Cultural Shift Is Contagious

This wouldn’t have happened under a culture of cowardice. But The Kennedy Effect is not about one man—it’s about the conditions that one man helped awaken. A groundswell of citizen awareness, independent science, and political courage is reshaping what we expect from our institutions. The new HHS, under Kennedy, is already signaling a similar rejection of pharmaceutical impunity, public health gaslighting, and data obfuscation.

Even if Zeldin’s motives are his own, his actions are part of the same current: a return to rational governance grounded in evidence, law, and the inviolable right of citizens to be protected from harm.

The Path Forward

Of course, the announcement is only a first step. Real accountability will require criminal investigations, restitution for poisoned communities, and the declassification of long-hidden corporate toxicology reports. It will require enforcement with teeth, not just templates. And it will require unwavering public vigilance.

But for the first time in a long time, it feels as if the machinery of government is beginning to rotate in the right direction—powered not by public relations, but by public will.

We should celebrate this moment. Not naively, but resolutely. Because while PFAS may be forever chemicals, corruption doesn’t have to be a forever condition.

With The Kennedy Effect gaining momentum, the American people may finally get the public health protection they deserve—not as a favor, but as a right.

Citations

1. Cancer (Kidney, Testicular):
Citation: Barry, V., Winquist, A., & Steenland, K. (2013). Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environmental Health Perspectives, 121(11–12), 1313–1318. https://doi.org/10.1289/ehp.1306615
Finding: Increased PFOA exposure was significantly associated with kidney and testicular cancers in a large population-based cohort.

2. Thyroid Dysfunction:
Citation: Wen, L. L., Lin, C. Y., Chien, K. L., Su, T. C., Chen, M. F., & Lin, L. Y. (2013). Association between serum perfluorinated chemicals and thyroid function in U.S. adults: The National Health and Nutrition Examination Survey 2007–2010. The Journal of Clinical Endocrinology & Metabolism, 98(9), E1456–E1464. https://doi.org/10.1210/jc.2012-4242
Finding: PFAS exposure, particularly PFOS and PFOA, was linked to altered thyroid hormone levels, suggesting endocrine disruption.

3. Liver Damage:
Citation: Bassler, J., Ducatman, A., Elliott, M., Wen, S., Wahlang, B., Barnett, J., & Cave, M. (2019). Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. Environmental Pollution, 247, 1055–1063. https://doi.org/10.1016/j.envpol.2019.01.064
Finding: Chronic exposure to PFAS was associated with markers of liver injury and dysfunction, including increased ALT levels and histological changes.

4. Immune Suppression and Reduced Vaccine Efficacy:
Citation: Grandjean, P., Andersen, E. W., Budtz-Jørgensen, E., Nielsen, F., Mølbak, K., Weihe, P., & Heilmann, C. (2012). Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307(4), 391–397. https://doi.org/10.1001/jama.2011.2034
Finding: Children with higher PFAS exposure had significantly reduced antibody responses to tetanus and diphtheria vaccines, raising concerns about immune system impairment.

5. Developmental Effects in Children:
Citation: Liew, Z., Ritz, B., von Ehrenstein, O. S., Bech, B. H., Nohr, E. A., & Fei, C. (2015). Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: A nested case–control study in the Danish National Birth Cohort. Environmental Health Perspectives, 123(4), 367–373. https://doi.org/10.1289/ehp.1408412
Finding: Prenatal PFAS exposure was associated with increased risk of ADHD and autism spectrum traits in offspring.

6. Elevated Cholesterol:
Citation: Nelson, J. W., Hatch, E. E., & Webster, T. F. (2010). Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environmental Health Perspectives, 118(2), 197–202. https://doi.org/10.1289/ehp.0901165
Finding: Higher serum PFAS levels were positively associated with total and LDL cholesterol in U.S. adults.

7. Pregnancy Complications:
Citation: Savitz, D. A., Stein, C. R., Bartell, S. M., Elston, B., Gong, J., & Shin, H. M. (2012). Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology, 23(3), 386–392. https://doi.org/10.1097/EDE.0b013e31824cdcdb
Finding: Elevated PFAS exposure was linked to increased risks of pregnancy-induced hypertension and low birth weight.